跳至主要内容
临床试验/ITMCTR2100004230
ITMCTR2100004230招募中1 期

Evaluation of Ttherapeutic effect of Bushen Zhiwang decoction on bone destruction in patients with Rheumatoid Arthritis and cohort study of bone destruction markers

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
16 至 70(—)
性别
All

入选标准

  • 1. Patients aged 16-70 years;
  • 2. Patients who meet the diagnostic criteria of RA and the diagnostic criteria of traditional Chinese medicine for liver and kidney deficiency syndrome;
  • 3. Patients with anteroposterior radiographs of both hands (including wrist) before and after treatment for one year;
  • 4. Patients with wrist X-ray grade I-III;
  • 5. Patients with informed consent.

排除标准

  • 1. Mental patients;
  • 2. Patients with severe malnutrition or severe damage of heart, brain, kidney and hematopoietic system;
  • 3. Patients with other rheumatic diseases;
  • 4. Patients with joint dysfunction;
  • 5. Patients with incomplete information.

研究者

发起方
Beijing University of Chinese Medicine

相似试验